Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients

References

• Kaplan MJ. Cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol 2006;18:289–97.
   PubMed Web of Science ®Google Scholar
• Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avron J, Setoguchi S, Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 2006;65:1608–12.
   PubMed Web of Science ®Google Scholar
• Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JAE, Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303–7.
   PubMed Web of Science ®Google Scholar
• Goodson NJ, Wiles NJ, Lunt M, Barret EM, Silman AJ, Symmons PM. Mortality in early inflammatory polyarthritis. Arthritis Rheum 2002;46:2010–19.
   PubMed Web of Science ®Google Scholar
• Van Leuven SI, Franssen R, Kastelein JJ, Levi M, Stroes ESG, Tak PP. Systemic inflammation as a risk factor for atherothrombosis. Rheumatology 2008;47:3–7.
   PubMed Web of Science ®Google Scholar
• Libby P. Inflammation in atherosclerosis. Nature 2002; 420:868–74.
   PubMed Web of Science ®Google Scholar
• Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003;23:168–75.
   PubMed Web of Science ®Google Scholar
• Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995;26:1235–41.
   PubMed Web of Science ®Google Scholar
• Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111–15.
   PubMed Web of Science ®Google Scholar
• Bonetti PO, Pumper GM, Higano ST, Holmes DR, Kuvin JT, Lerman A. Non-invasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 2004;44:2137–41.
   PubMed Web of Science ®Google Scholar
• Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet 2009;373:659–72.
   PubMed Web of Science ®Google Scholar
• Lu MC, Lai NS, Yu HC, Huang HB, Hsieh SC, Yu CL. Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte/macrophages and stimulate tumor necrosis factor alpha production. Arthritis Rheum 2010;62:1213–23.
   PubMed Web of Science ®Google Scholar
• Lopez-Longo FJ, Oliver-Minarro D, de la Torre I, Gonzalez-Diaz de Rabago E, Sanchez-Ramon S, Rodriguez-Mahou M, Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Rheum 2009;61:419–24.
   PubMed Web of Science ®Google Scholar
• Szekanecz Z, Kerekes G, Der H, Sandor Z, Szabo Z, Vegvari A, Accelerated atherosclerosis in rheumatoid arthritis. Ann N Y Acad Sci 2007;1108:349–58.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1984;27:361–8.
   PubMed Web of Science ®Google Scholar
• Salaffi F, Cimmino MA, Leardini G, Gasparini S, Grassi W. Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI). Clin Exp Rheumatol 2009;27:552–9.
   PubMed Web of Science ®Google Scholar
• Uhlig T, Haavardsholm EA, Kvien TK. Comparison of the Health Assessment Questionnaire (HAQ) and the modified HAQ (MHAQ) in patients with rheumatoid arthritis. Rheumatology 2006;45:454–8.
   PubMed Web of Science ®Google Scholar
• Bonetti PO, Barsness GW, Keelan PC, Schnell TI, Pumper GM, Kuvin JT, Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003;41:1761–8.
   PubMed Web of Science ®Google Scholar
• Rozanski A, Qureshi E, Bauman M, Reed G, Pillar G, Diamond GA. Peripheral arterial responses to treadmill exercise among healthy subjects and atherosclerotic patients. Circulation 2001;103:2084–9.
   PubMed Web of Science ®Google Scholar
• Kuvin JT, Patel AR, Sliney KA, Pandian NG, Sheffy J, Schnall RP, Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 2003;146:168–74.
   PubMed Web of Science ®Google Scholar
• Lopez-Longo FJ, Sanches-Ramon S, Carreno L. The value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: do they imply new risk factors? Drug News Perspect 2009;22:543–8.
   PubMedGoogle Scholar
• Kahn F, Galarraga B, Belch JJ. The role of endothelial function and its assessment in rheumatoid arthritis. Nat Rev Rheumatol. 2010;6:253–61.
   PubMed Web of Science ®Google Scholar
• Hein TW, Singh U, Vasquez-Vivar J, Devaraj S, Kuo L, Jialal I, Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis 2009;206:61–8.
   PubMed Web of Science ®Google Scholar
• Yang Z, Ming XF. Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res 2006;4:53–65.
   PubMedGoogle Scholar
• Surdacki A, Martens-Lobenhoffer J, Wloch J, Gluszko P, Rakowski T, Dubiel JS, Plasma asymmetric dimethylarginine is related to anticitrullinated protein antibodies in rheumatoid arthritis. Metabolism 2009;58:316–18.
   PubMed Web of Science ®Google Scholar
• Turiel M, Tomasoni L, Sitia S, Gianturco L, Ricci C, Atzeni F, Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis. Cardiovasc Ther 2010;28:e53–64.
   PubMed Web of Science ®Google Scholar
• Pertovaara M, Kahonen M, Juonala M, Laitinen T, Taittonen L, Lehtimaki T, Autoimmunity and atherosclerosis: the presence of antinuclear antibodies is associated with decreased carotid elasticity in young women. The Cardiovascular Risk in Young Finns Study. Rheumatology 2009;48:1553–6.
   Google Scholar
• Pereira I, Laurindo I, Burlingame R, Anjos L, Viana V, Leon E, Autoantibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis. Joint Bone Spine 2008; 75:416–21.
   PubMed Web of Science ®Google Scholar
• Kerekes G, Szekanecz Z, Dér H, Sandor Z, Lakos G, Muszbek L, Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol 2008;35:398–406.
   PubMed Web of Science ®Google Scholar
• Solomon DH, Avorn J, Katz JN, Weinblatt ME, Setoguchi S, Levin R, Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:3790–8.
   PubMed Web of Science ®Google Scholar
• Del Rincon I, O'Leary DH, Haas RW, Escalante A. Effect of glucocorticoids on the arteries in rheumatoid arthritis. Arthritis Rheum 2004;50:3813–22.
   PubMed Web of Science ®Google Scholar
• Lopez de Guzman A, de D Garcia Diaz J, Diez-Perez de la Vacas MI, Cuende Quintana E, Sanchez Atrio A, Sivera Monzo I. [Coronary calcification and subclinical myocardial dysfunction in rheumatoid arthritis], in Spanish. Rev Clin Esp 2009; 209:428–32.
   PubMed Web of Science ®Google Scholar
• Fietta P, Delsante G. Atherogenesis in rheumatoid arthritis: the ‘rheumatoid vasculopathy’? Acta Biomed 2009;80:177–86.
   PubMedGoogle Scholar